by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
by Others
Composition:
PAZOPANIB-400MG
Uses:
Kidney cancer, Soft tissue cancer
Medicinal Benefits:
Votrient 400 mg Tablet is a ' tyrosine kinase inhibitor (TKI)', that stops the uncontrolled growth and spread of cancerous cells. Votrient 400 mg Tablet is effective in treating thyroid, liver and kidney cancer. It acts by stopping the action of the abnormal protein that is responsible for the multiplication of cancerous cells. Whenever a new healthy cell is formed it undergoes a usual process of maturity. Cancerous cells form new cells more quickly so Votrient 400 mg Tablet targets cancerous cells and blocks the action of Tyrosine kinases enzymes (responsible for causing cancer). It also decreases the blood supply to cancer tumors to slow down the growth of the tumor. In this way, Votrient 400 mg Tablet stops the production, spread and growth of cancerous cells in the body.
Votrient 400 mg Tablet is safe to be taken by a diabetic person. However, take Votrient 400 mg Tablet only after asking with a doctor as they may adjust the dosing according to the condition of the patient.
Votrient 400 mg Tablet is restricted to use in pregnancy. A woman needs to have a negative pregnancy test before starting treatment with this medicine. It is better to use effective birth control methods to prevent pregnancy while taking this medicine or for at least 6 months after taking the last dose of Votrient 400 mg Tablet .
Votrient 400 mg Tablet should be stopped in cases where a person faces serious side effect that affects the quality of life. Otherwise, you need to keep taking Votrient 400 mg Tablet until your doctor asks you to stop it.
Before your doctor prescribes you Votrient 400 mg Tablet , tell them if you have heart problems, high blood pressure, bleeding issues, surgery or an electrolyte imbalance (like abnormal levels of magnesium, calcium, or potassium in the blood).
Votrient 400 mg Tablet is restricted to use in persons who are sensitive to any of its constituents or have squamous cell lung cancer or already taking carboplatin and paclitaxel.